The Information Commissioner’s Office has finalised new standard clauses (known as the IDTA, or ‘international data transfer agreement’) to support international data flows. Find out how to use the new clauses in our insight.

If you are thinking of taking legal action regarding a tenancy, considering whether you have done all you can to assist the tenant beforehand is vital. We summarise a recent example and explain the practical aspects you need to consider.

This year is likely to see a resurgence of non-Covid trials which have been postponed or paused in the last two years, and new trials for Covid treatments and vaccines (e.g. those based on conventional vaccine technology).

Delays to non-Covid treatment is the leading type of claim against NHS Trusts to date, followed by Hospital-Acquired Covid (HAC) and failure to treat Covid appropriately.

The vast majority of the inquest cases relate to acquisition of Covid-19 during hospital admission and staffing/resource issues. In a recent case a Coroner was critical of a decision not to escalate a patient’s care to ICU.

The Court of Appeal held that the Chief Constable was liable for any disability discrimination by the statutory police misconduct panel that had determined disciplinary allegations against the claimant police officer.

We have summarised the key temporary variations to primary care contracts as well as the changes to the 2021/22 Network Contract Directed Enhanced Services (DES).

Concussion injury and its consequences continue to be in the news, with group litigation planned by both rugby and football players. We could see more claims of this nature, including from other sports where head injury is a risk.

In this year’s forward view, we consider issues ranging from fixed recoverable costs in clinical negligence claims, claims resulting from COVID-19 treatment, major inquiries, clinical trials and healthcare technology.

The government is opening a consultation on fixed recoverable costs in low value clinical negligence claims. The proposed scheme aims to avoid litigation and speed up the exchange of evidence for faster agreement on liability, causation and quantum.

Two cases awaiting decisions from the Court of Appeal could have a significant impact for healthcare organisations.

Safety of two medicines (Primodos and Sodium Valproate) and one device (pelvic mesh) was at the heart of the report of the Independent Medicines and Medical Devices Safety Review. Read the latest update on this topic.